News

Inaugural North West Family Fun & Information Day

Retina UK joined forces with Henshaws; Royal Society for Blind Children and St Vincent’s School for the Blind to hold a family event in Liverpool on Sunday 10 March. Despite …

Retina UK Challenge Series

The Retina UK Challenge Series is a brand new way to approach your 2019 fundraising with different activities to get involved in throughout the year. With a range of activities …

Retina UK welcomes London Marathon’s guide runner policy U-turn

Retina UK has welcomed the news that guide runners will be fully recognised for their achievements at this year’s London Marathon after a change of heart by the event’s organisers. …

New developments in the search for treatments for Stargardt disease

Researchers funded by Retina UK have contributed to the early development of potential new treatments for Stargardt disease, with their findings recently published in the journal Genetics in Medicine. Stargardt …

Retina UK launches new Tandem Cycling Event

Retina UK has launched a brand new event for 2019. From 11th-13th October, Retina UK supporters will come together to cycle 100 miles over two days along Hadrian's Cycleway. Supported …

Promising interim results for trial of potential new treatment for LCA10

Highly promising interim results from an early phase clinical trial of a potential new treatment for Leber’s congenital amaurosis 10 (LCA10), caused by mutations in the CEP290 gene, have been …

“First-in-class” treatment for vision loss in Usher syndrome takes a step towards clinical testing

A potentially transformative new treatment for vision loss in Usher syndrome type 2 has been given the go-ahead for initial clinical testing in a small number of adults living with …

Retina UK Ambassasor wins Venus Award for Inspirational Woman of the Year

Award winning business woman, entrepreneur and Retina UK ambassador Seema Flower recently won the award for the London 2018 Venus Award Inspirational Woman of the Year. At a ceremony that …

First gene editing treatment moves towards clinical trials

The US Food & Drug Administration (FDA) has given the go-ahead for clinical testing of what could be the first gene editing treatment to be used in inherited eye disease. …

Gene therapy for RPE65 gene approved for use in EU

The gene therapy Luxturna has won European regulatory approval for the treatment of inherited retinal dystrophy caused by mutations in the RPE65 gene. This milestone decision was made by the …

Ophthalmology clinical research activity on the increase in the UK

Ophthalmology research in the NHS has grown and become more accessible to patients over the last eight years, according to a newly published report in the journal Eye. This is …

Surfing with sight loss – fun and freedom

By Victoria Claire, Retina UK Ambassador Surfing was always something that appealed to me – I loved the idea of it, the culture, the fashion – when I was younger …